title: Administration of nonanticoagulant heparin inhibits the loss of glycosaminoglycans from xenogeneic cardiac grafts and prolongs graft survival.
authors.affiliation: Department of Surgery, University of Minnesota, Minneapolis.
authors.forename: R B
authors.initials: RB
authors.lastname: Stevens
authors.forename: Y L
authors.initials: YL
authors.lastname: Wang
authors.forename: H
authors.initials: H
authors.lastname: Kaji
authors.forename: J
authors.initials: J
authors.lastname: Lloveras
authors.forename: A
authors.initials: A
authors.lastname: Dalmasso
authors.forename: F H
authors.initials: FH
authors.lastname: Bach
authors.forename: P
authors.initials: P
authors.lastname: Rubinstein
authors.forename: D E
authors.initials: DE
authors.lastname: Sutherland
authors.forename: J L
authors.initials: JL
authors.lastname: Platt
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism*; D006025:Glycosaminoglycans / Q000378:metabolism*; D006084:Graft Rejection / Q000517:prevention & control; D006085:Graft Survival / Q000502:physiology*; D006168:Guinea Pigs; D016027:Heart Transplantation / Q000502:physiology*; D006493:Heparin / Q000494:pharmacology*; D006497:Heparan Sulfate / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D051381:Rats; D011917:Rats, Inbred Lew; D013552:Swine; D014183:Transplantation, Heterologous / Q000502:physiology*; D014185:Transplantation, Isogeneic / Q000502:physiology
chemical_list: D006025:Glycosaminoglycans; D006493:Heparin; D006497:Heparan Sulfate